Phase 2
๐ Investigational Drug / Biologic
NCT07129993
Study of Datopotamab Deruxtecan Plus Carboplatin or Cisplatin Versus Gemcitabine Plus Carboplatin or Cisplatin in Participants With Locally Advanced or Metastatic Urothelial Carcinoma
๐ Research Site โ Fullerton, California
View Study & Screener โ